As part of the EU project GAITREHAB prototypes of TEDIRO's therapy and diagnosis robot will be used in clinics in four European countries. The German Medtech startup will test the usability of the device with therapists and users to gain an impression of the acceptance of the robot in the clinical environment.
GAITREHAB is a project that aims at helping clinics address acute pandemic and post-pandemic challenges in orthopedic rehabilitation by deploying the worlds’ first mobile robot for autonomous gait training on crutches.
The first application of TEDIROs robot focusses patients with affected lower limbs across a broad range of indications, addressing a rehabilitation mass market with about 8 million cases in Europe alone. While offering robot-assisted self-training, clinics can reduce direct patient contact during pandemic and, during a post-pandemic phase. Furthermore the robot supports clinics to maintain a high level of treatment quality despite the shortage of skilled labor.
The TEDIROs robotic system will be placed in four acute and rehabilitation clinics in four different European countries for a range of different indications like knee arthroplasty, ankle joint surgery, etc. During the deployment phases in these clinics, data will be collected on “pandemic potential of the technology”, healthcare systems insights for subsequent product launch and data for product approval.
Explorative usability study of a mobile robot in a clinical context
The study has two parts: Primary study goal is an explorative analysis of the usability of the sign-up process of the device. Also patients will evaluate a demonstration of the training performed by clinical staff to provide estimations on its use. The second part involves a usability study of the therapy management system with therapists using it to set up training plans, set up patients, and view training results.